Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus
- PMID: 2345906
- DOI: 10.1016/0035-9203(90)90395-u
Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus
Abstract
The impact of ivermectin mass treatment on ocular onchocerciasis was studied in a holoendemic focus of blinding onchocerciasis in Ghana. A cohort of 417 persons, 369 of whom were treated, was followed up at 4 and 12 months after treatment. The mean ocular microfilarial load in the anterior chamber of the eye and in the cornea of treated persons was reduced to less than 20% and 10% of the pretreatment levels respectively at the 4 months follow-up but had increased significantly by 12 months. Lesions of the eye at the advanced stage of development remained stable. There was significant regression of early lesions of the anterior segment of the eye, particularly iridocyclitis, after ivermectin treatment. In view of the substantial increase of ocular microfilarial loads after 12 months, 6-monthly treatment may be indicated in such highly endemic foci. However, long-term observation is needed to give a correct estimate of the full benefit to be derived from mass treatment with ivermectin.
Similar articles
-
Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):267-71. doi: 10.1016/0035-9203(91)90051-y. Trans R Soc Trop Med Hyg. 1991. PMID: 1887490
-
Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone.Lancet. 1991 Nov 2;338(8775):1100-3. doi: 10.1016/0140-6736(91)91963-u. Lancet. 1991. PMID: 1682543 Clinical Trial.
-
A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.J Infect Dis. 1991 Feb;163(2):376-80. doi: 10.1093/infdis/163.2.376. J Infect Dis. 1991. PMID: 1988521 Clinical Trial.
-
Ivermectin treatment of ocular onchocerciasis.Acta Leiden. 1990;59(1-2):201-6. Acta Leiden. 1990. PMID: 2198751 Review.
-
Onchocercal eye disease and the impact of Mectizan treatment.Ann Trop Med Parasitol. 1998 Apr;92 Suppl 1:S11-22. doi: 10.1080/00034989859519. Ann Trop Med Parasitol. 1998. PMID: 9861263 Review.
Cited by
-
Impact of annual dosing with ivermectin on progression of onchocercal visual field loss.Bull World Health Organ. 1997;75(3):229-36. Bull World Health Organ. 1997. PMID: 9277010 Free PMC article. Clinical Trial.
-
Treatment of onchocerciasis.Drugs. 1996 Dec;52(6):861-9. doi: 10.2165/00003495-199652060-00007. Drugs. 1996. PMID: 8957156 Review.
-
Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.Drugs. 1991 Oct;42(4):640-58. doi: 10.2165/00003495-199142040-00007. Drugs. 1991. PMID: 1723366 Review.
-
Points of action in the campaign against blindness in developing countries.Doc Ophthalmol. 1991;78(3-4):285-305. doi: 10.1007/BF00165693. Doc Ophthalmol. 1991. PMID: 1790753 Review.
-
Onchocerciasis in Ecuador: evolution of chorioretinopathy after amocarzine treatment.Br J Ophthalmol. 1996 Apr;80(4):337-42. doi: 10.1136/bjo.80.4.337. Br J Ophthalmol. 1996. PMID: 8703886 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources